Great news at the end of the year! PREP lab got significant close to 1.1 million euro funding for 2years from Business Finland TUTLI project. Project will focus to investigate commercial potential of PREP inhibitors, and performing research aiming to commercialization. This is significant step to take PREP lab research towards clinical trials and drug on market.
Photo: Business Finland